Premier Research · 5 hours ago
Site Identification Lead
Maximize your interview chances
BiopharmaBiotechnology
Insider Connection @Premier Research
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Oversees site outreach for post award Site ID activities, standalone paid feasibility activities and pre-award blinded site outreach activities.
Facilitates an internal Site ID Kick Off Meeting (Site ID KOM) with Project Management, Clinical Management, Clinical Strategy Lead, Medical Informatics, and other functional leads to obtain relevant information for site identification and selection, prior to start of Site ID activities.
Progresses and tracks in the CTMS site identification activities according to study timelines.
Utilizes historic site performance metrics, cluster sites, partner sites, Medical Informatics data, and other data to identify potential sites.
Creates, delivers, and obtains the SRQ from all PI’s and/or sites for study participation consideration. Designs, distributes, tracks and reviews SRQs for completeness, site capability and availability based on project specific requirements and needs.
Assists in the design and implementation of all relevant systems including, but not limited to, the site identification metrics and reporting, surveys, etc.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Undergraduate degree or its international equivalent in a clinical, science, or health-related field from an accredited institution or a licensed healthcare professional
Preferred
Experience in clinical trials support, clinical monitoring, site identification/selection or pharmaceutical industry preferred.
Benefits
Health insurance
Retirement plans
Paid time off
Company
Premier Research
Premier Research is a biotech startup that helps biopharmaceutical and medical device companies bring their developments.
Funding
Current Stage
Late StageTotal Funding
unknownKey Investors
Metalmark Capital
2016-10-17Series Unknown· Undisclosed
2008-03-20Acquired· by ECI Partners ($118.95M)
Recent News
Company data provided by crunchbase